Tudor Investment Corp
IMVT icon

Tudor Investment Corp’s Immunovant IMVT Stock Holding History

Tudor Investment Corp’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,600
Closed -$651K – 3944
2025
Q4 		$651K Sell
25,600
-65,166
-72% -$1.45M ﹤0.01% 2558
2025
Q3 		$1.46M Buy
+90,766
New +$1.47M ﹤0.01% 2010
2024
Q2 		– Sell
-87,397
Closed -$2.82M – 2534
2024
Q1 		$2.82M Buy
87,397
+49,055
+128% +$1.79M 0.02% 858
2023
Q4 		$1.62M Buy
+38,342
New +$1.41M 0.01% 1211
2023
Q3 		– Sell
-14,333
Closed -$272K – 2553
2023
Q2 		$272K Sell
14,333
-52,686
-79% -$983K ﹤0.01% 2059
2023
Q1 		$1.04M Buy
+67,019
New +$1.16M 0.02% 1171

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Tudor Investment Corp's IMVT Position: Q1 2026 in Review

Tudor Investment Corp sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 25,600 shares — an estimated $651K sold.

Tudor Investment Corp first reported a position in IMVT in Q1 2023 and held it in 6 quarters. The position peaked at $2.82M in Q1 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Tudor Investment Corp reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 25,600 Immunovant shares in Q1 2026, an estimated $651K.
  • Tudor Investment Corp first reported a position in Immunovant in Q1 2023 and held it in 6 quarters.
  • Tudor Investment Corp's Immunovant position peaked at $2.82M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.